Biota Pharmaceuticals (BOTA) Reports Q4 Loss of $0.29/Share

Biota Pharmaceuticals (NASDAQ: BOTA) reported Q4 EPS of ($0.29), versus ($0.23) reported last year. Revenue for the quarter came in at $8.5 million, versus $9.3 million reported last year.

For earnings history and earnings-related data on Biota Pharmaceuticals (BOTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Diana Shipping withdraws bid to acquire Genco Shipping